Skip to main content

Advertisement

SpringerLink
Log in

Die invalidenversicherungsrechtliche Begutachtung in der Schweiz vor dem Hintergrund der letzten Gesetzesrevision und neueren Rechtsprechung

The disability insurance legal assessment in Switzerland against the background of the latest legislative amendments and new jurisprudence

  • Übersicht
  • Published:
Forensische Psychiatrie, Psychologie, Kriminologie Aims and scope Submit manuscript

Zusammenfassung

In der Schweiz gibt es 11 verschiedene, historisch gewachsene Sozialversicherungen, deren grundsätzliche Ausgestaltung im Allgemeinen Teil des Sozialversicherungsgesetzes (ATSG) dargelegt ist. Die soziale Sicherung für behinderte Menschen und solche mit chronischen Erkrankungen wird u. a. von der Invalidenversicherung gewährleistet, die durch das Bundesgesetz über die Invalidenversicherung – aktuell in der 6. Revision – geregelt wird.

Da sich die Rechtsprechung bezüglich der Invalidenversicherung in den letzten 10 Jahren erheblich gewandelt hat – was sich insbesondere auf die Leistungszusprache bei psychischen Störungen auswirkt – soll der vorliegende Beitrag einen Überblick über die für den medizinischen Experten relevanten juristischen Aspekte geben.

Es ist hervorzuheben, dass die Rechtsprechung Prinzipien zur Einordung von Folgen spezifischer Krankheitsentitäten normativ festgelegt und diese im letzten Jahrzehnt weiterausgebaut hat. Die vom Rechtsanwender vorgenommene Prüfung der „willentlichen Überwindbarkeit“ stellt dabei auf einen Kriterienkatalog ab, der aus medizinischer Sicht nicht ausreichend belegt ist. In der juristischen Literatur der Schweiz wird diese gegenwärtige (Rechts-)Praxis kontrovers diskutiert, und Anpassungen werden erwogen.

Abstract

There are 11 different historically established social security insurances in Switzerland. Social security for disabled and chronically ill people is mostly covered by the disability insurance. The disability insurance is governed by a federal law which has been revised six times, the last amendments having been introduced in 2012.

The disability insurance legislation has changed much in the past 10 years and this has had a particularly great impact on the benefits awarded for psychiatric disorders. This article outlines several important facets of the disability insurance legislation relevant to psychiatric work capacity evaluations. Of particular interest are the special legal rules applied to specific illness groups, which have been expanded during the last decade. The concept of “voluntary surmountability” has arguably had the most impact and is based on a catalogue of criteria with an insufficient scientific foundation. The impact and possible changes of the current jurisdiction is currently being discussed in the Swiss juristic literature and amendments are under consideration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 10. Aufl. der Internationalen statistischen Klassifikation der Krankheiten und verwandter Gesundheitsprobleme.

Literatur

  1. Abbey SE, Garfinkel P (1991) Neurasthenia and chronic fatigue syndrome. Am J Psychiatry 148(12):1638–1646

    Article  CAS  PubMed  Google Scholar 

  2. Abram KM, Teplin LA, King DC, Longworth SL, Emanuel KM, Romero EG, McClelland GM, Dulcan MK, Washburn JJ, Welty LJ (2013) PTSD, trauma, and comorbid psychiatric disorders in detained youth

  3. Addington J, Duchak V (1997) Reasons for substance use in schizophrenia. Acta Psychiatr Scand 96(5):329–333

    Article  CAS  PubMed  Google Scholar 

  4. Afari N, Buchwald D (2003) Chronic fatigue syndrome: a review. Am J Psychiatry 160(2):221–236

    Article  PubMed  Google Scholar 

  5. Andrews G, Hobbs MJ, Borkovec TD, Beesdo K, Craske MG, Heimberg RG, Rapee RM, Ruscio AM, Stanley MA (2010) Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V. Depress Anxiety 27(2):134–147

    Article  PubMed  Google Scholar 

  6. Angst J, Gamma A, Baldwin DS, Ajdacic-Gross V, Rössler W (2009) The generalized anxiety spectrum: prevalence, onset, course and outcome. Eur Arch Psychiatry Clin Neurosci 259(1):37–45

    Article  PubMed  Google Scholar 

  7. Anner J, Schwegler U, Kunz R, Trezzini B, de Boer W (2012) Evaluation of work disability and the international classification of functioning, disability and health: what to expect and what not. BMC Public Health 12(1):470

    Article  PubMed Central  PubMed  Google Scholar 

  8. Antonaci F, Nappi G, Galli F, Manzoni GC, Calabresi P, Costa A (2011) Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain 12(2):115–125

    Article  PubMed Central  PubMed  Google Scholar 

  9. Auerbach H, Bollag Y, Eichler K, Gyr N, Imhof D, Stöhr S MGS Medizinische Gutachtensituation in der Schweiz:„Studie zur Einschätzung der Marktsituation und zur Schaffung von Markttransparenz und Qualitätssicherung“ publiziert auf: http://www.swiss-insurance-medicine.ch/de/gutachtensituation-schweiz.html

  10. Bair MJ, Robinson RL, Katon W, Kroenke K (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163(20):2433–2445

    Article  PubMed  Google Scholar 

  11. Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K (2008) Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med 70(8):890

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Bansal A, Bradley A, Bishop K, Kiani-Alikhan S, Ford B (2012) Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun 26(1):24–31

    Article  CAS  PubMed  Google Scholar 

  13. Barsky AJ, Borus JF (1999) Functional somatic syndromes. Ann Intern Med 130(11):910–921

    Article  CAS  PubMed  Google Scholar 

  14. Beesdo K, Jacobi F, Hoyer J, Low NC, Höfler M, Wittchen H-U (2010) Pain associated with specific anxiety and depressive disorders in a nationally representative population sample. Soc Psychiatry Psychiatr Epidemiol 45(1):89–104

    Article  PubMed  Google Scholar 

  15. Berger AM, Gerber LH, Mayer DK (2012) Cancer‐related fatigue. Cancer 118(8 Suppl):2261–2269

    Article  PubMed  Google Scholar 

  16. Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV (1995) Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152(11):1652–1658

    Article  CAS  PubMed  Google Scholar 

  17. Billiard M, Besset A (2003) Idiopathic hypersomnia. Sleep. Springer, Springer US, S 429–435

  18. Bombardier CH, Buchwald D (1996) Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use. Med Care 34(9):924–930

    Article  CAS  PubMed  Google Scholar 

  19. BSV BfS (2014) Statistiken zur sozialen Sicherheit – IV-Statistik 2013. In: BSV BfS (Hrsg) http://www.bfs.admin.ch/bfs/portal/de/index/news/publikationen.html?publicationID=5586

  20. BSV) BfS (2014) Kreisschreiben über Invalidität und Hilflosigkeit in der Invalidenversicherung (KSIH). http://www.bsv.admin.ch/vollzug/documents/index/page:2/lang:deu/category:3421

  21. Burton C (2003) Beyond somatisation: a review of the understanding and treatment of medically unexplained physical symptoms (MUPS). Br J Gen Pract 53(488):231–239

    PubMed Central  PubMed  Google Scholar 

  22. Campos MP, Hassan B, Riechelmann R, Del Giglio A (2011) Cancer-related fatigue: a practical review. Ann Oncol 22(6):1273–1279

  23. Chambers RA, Krystal JH, Self DW (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50(2):71–83

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Christley Y, Duffy T, Everall IP, Martin CR (2013) The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: revisiting the enigma. Curr Psychiatry Rep 15(4):1–9

    Article  Google Scholar 

  25. Christley Y, Duffy T, Martin CR (2012) A review of the definitional criteria for chronic fatigue syndrome. J Eval Clin Pract 18(1):25–31

    Article  PubMed  Google Scholar 

  26. Clauw D, Chrousos G (1997) Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4(3):134–153

    CAS  PubMed  Google Scholar 

  27. Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF (2005) Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry

  28. Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64 (5):566–576

    Article  PubMed  Google Scholar 

  29. Creed F, Guthrie E, Fink P, Henningsen P, Rief W, Sharpe M, White P (2010) Is there a better term than „medically unexplained symptoms“? J Psychosom Res 68(1):5–8

    Article  PubMed  Google Scholar 

  30. Croft P (2002) The epidemiology of chronic widespread pain. J Musculoskelet Pain 10(1–2):191–199

    Article  Google Scholar 

  31. De Waal MW, Arnold IA, Eekhof JA, Van Hemert AM (2004) Somatoform disorders in general practice prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 184(6):470–476

    Article  PubMed  Google Scholar 

  32. Dickmann J, Broocks A (2007) Das psychiatrische Gutachten im Rentenverfahren-wie reliabel? Fortschr Neurol Psychiatr 75(7):397–401

    Article  CAS  PubMed  Google Scholar 

  33. Dilling H, Mombour W, Schmidt MH, Organization WH (1991) Internationale Klassifikation psychischer Störungen: ICD-10, Kapitel V (F, klinisch-diagnostische Leitlinien/hrsg. von H. Dilling, W. Mombour und MH Schmidt

  34. Eriksen HR, Ursin H (2002) Sensitization and subjective health complaints. Scand J Psychol 43(2):189–196

    Article  PubMed  Google Scholar 

  35. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, Collier D, Wessely S, Cleare A (2010) Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 5(1):e8519

    Article  PubMed Central  PubMed  Google Scholar 

  36. Essau CA (2007) Course and outcome of somatoform disorders in non-referred adolescents. Psychosomatics 48(6):502–509

    Article  PubMed  Google Scholar 

  37. Fink P, Schröder A (2010) One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res 68(5):415–426

    Article  PubMed  Google Scholar 

  38. Foerster K, Dreßing H (2010) Psychiatrische Begutachtung: Ein praktisches Handbuch für Ärzte und Juristen. Elsevier, Urban & Fischer, München

  39. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Int Med 121(12):953–959

    Article  CAS  PubMed  Google Scholar 

  40. Galatzer‐Levy IR, Nickerson A, Litz BT, Marmar CR (2013) Patterns of lifetime PTSD comorbidity: a latent class analysis. Depress Anxiety 30(5):489–496

    Article  PubMed  Google Scholar 

  41. Glantz MD, Anthony JC, Berglund PA, Degenhardt L, Dierker L, Kalaydjian A, Merikangas KR, Ruscio AM, Swendsen J, Kessler RC (2009) Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychol Med 39(8):1365–1377

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S (2003) The health and productivity cost burden of the„ top 10“ physical and mental health conditions affecting six large US employers in 1999. J Occup Environ Med 45(1):5–14

    Article  PubMed  Google Scholar 

  43. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61(8):807–816

    Article  PubMed  Google Scholar 

  44. Harris AM, Orav EJ, Bates DW, Barsky AJ (2009) Somatization increases disability independent of comorbidity. J Gen Intern Med 24(2):155–161

    Article  PubMed Central  PubMed  Google Scholar 

  45. Hasin DS, Goodwin RD, Stinson FS, Grant BF (2005) Epidemiology of major depressive disorder: results from the national epidemiologic survey on alcoholism and related conditions. Arch Gen Psychiatry 62(10):1097–1106

    Article  PubMed  Google Scholar 

  46. Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64(7):830–842

    Article  PubMed  Google Scholar 

  47. Häuser W, Kosseva M, Üceyler N, Klose P, Sommer C (2011) Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta‐analysis. Arthritis Care Res (Hoboken) 63(6):808–820

    Article  Google Scholar 

  48. Hausotter W (2004) Begutachtung somatoformer und funktioneller Störungen. Elsevier, Urban & Fischer, München

  49. Hoffman D, Dukes E (2008) The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF‐36 or the SF‐12. Int J Clin Pract 62(1):115–126

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Jackson J, Fiddler M, Kapur N, Wells A, Tomenson B, Creed F (2006) Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. J Psychosom Res 60(4):357–363

    Article  PubMed  Google Scholar 

  51. Jacobi F, Wittchen H-U, Hölting C, Höfler M, Pfister H, Müller N, Lieb R (2004) Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 34(4):597–611

    Article  CAS  PubMed  Google Scholar 

  52. Jeger J (2007) Somatoforme Schmerzstörungen–Medizin und Recht im Widerspruch? Eine Beurteilung aus ärztlicher Sicht. Ther Umsch 64(8):415–423

    Article  CAS  PubMed  Google Scholar 

  53. Jeger J (2008) Die Beurteilung der medizinischen Zumutbarkeit – Was darf dem erkrankten oder verunfallten Menschen zugemutet werden? Verlag Stämpfli, Bern

  54. Jeger J (2011) Die Entwicklung der «FOERSTER-Kriterien» und ihre Übernahme in die bundesgerichtliche Rechtsprechung: Geschichte einer Evidenz. Jusletter wwwjusletterch

  55. Jeger J (2011) Wer bemisst invaliditätsfremde (soziokulturelle und psychosoziale) Ursachen der Arbeitsunfähigkeit – der Arzt oder der Jurist?, Bd 57. Sozialversicherungsrechtstagung 2008. Schriftenreihe des Instituts für Rechts-wissenschaft und Rechtspraxis IRP-HSG, St. Gallen. Schaffhauser R/Schlauri F

  56. Johnson TP, Mott JA (2001) The reliability of self‐reported age of onset of tobacco, alcohol and illicit drug use. Addiction 96(8):1187–1198

    Article  CAS  PubMed  Google Scholar 

  57. Kessler R (2000) The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research. Acta Psychiatr Scand Suppl 102(s406):7–13

    Article  Google Scholar 

  58. Kessler RC (2004) The epidemiology of dual diagnosis. Biol Psychiatry 56(10):730–737

    Article  PubMed  Google Scholar 

  59. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ (1996) The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 66(1):17–31

  60. Kessler RC, Chiu WT, Demler O, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62(6):617–627

    Article  PubMed Central  PubMed  Google Scholar 

  61. Kisely S, Goldberg D, Simon G (1997) A comparison between somatic symptoms with and without clear organic cause: results of an international study. Psychol Med 27(5):1011–1019

    Article  CAS  PubMed  Google Scholar 

  62. Knudsen AK, Henderson M, Harvey SB, Chalder T (2011) Long-term sickness absence among patients with chronic fatigue syndrome. Br J Psychiatry 199(5):430–431

    Article  PubMed  Google Scholar 

  63. Kroenke K, Price RK (1993) Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Intern Med 153(21):2474–2480

    Article  CAS  PubMed  Google Scholar 

  64. Kuhn TS (1992) Die Entstehung des Neuen: Studien zur Struktur der Wissenschaftsgeschichte, 4. Aufl. Suhrkamp, Frankfurt a. M.

    Google Scholar 

  65. Leiknes KA, Finset A, Moum T, Sandanger I (2008) Overlap, comorbidity, and stability of somatoform disorders and the use of current versus lifetime criteria. Psychosomatics 49(2):152–162

    Article  PubMed  Google Scholar 

  66. Lieb R, Zimmermann P, Friis RH, Höfler M, Tholen S, Wittchen H-U (2002) The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective-longitudinal community study. Eur Psychiatry 17(6):321–331

    Article  PubMed  Google Scholar 

  67. Linden M, Baron S, Muschalla B (2009) Mini-ICF-Rating für psychische Störungen (Mini-ICF-APP). Ein Kurzinstrument zur Beuteilung von Fähigkeits-bzw Kapazitätsstörungen bei psychischen Störungen. Göttingen: Hans Huber

  68. Ludwig C (2006) Gutachtenqualität im Unfallversicherungsbereich. Suva-Med Mitt 77:5–16

    Google Scholar 

  69. Marinus J, Moseley GL, Birklein F, Baron R, Maihöfner C, Kingery WS, van Hilten JJ (2011) Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol 10(7):637–648

    Article  PubMed  Google Scholar 

  70. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, Bijl R, Borges G, Caraveo-Anduaga JJ, Dewit DJ et al (1998) Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in psychiatric epidemiology. Addict Behav 23(6):893–907

    Article  CAS  PubMed  Google Scholar 

  71. Meyer BPDiU (2014) Freier Wille aus Sicht der Justiz und seine Auswirkungen auf die Rechtsprechung. In: Ebner DmG (Hrsg). Psychiatrie & Neurologie Nr. 4/2014

  72. Liebrenz M, Canela C, Schleifer R, Seifritz E (2013) Psychiatrische Expertise/juristische Entscheide im sozialversicherungsrecht Expertise - Berührungspunkte erkennen und Missverständnisse vermeiden. InFo Neurol Psychiatr 11:6

  73. Milberger S, Biederman J, Faraone SV, Wilens T, Chu MP (1997) Associations between ADHD and psychoactive substance use disorders. Am J Addict 6(4):318–329

    CAS  PubMed  Google Scholar 

  74. World Health Organization (Hrsg) (2001) International Classification of Functioning. Disability & Health. Aufl. 1, WHO

  75. Mosimann H-J (2014) Perspektiven der Überwindbarkeit. SZS

  76. Müller JP (2014) Verfahrensgerechtigkeit in der Sozialversicherung – IV-Renten für Schmerzpatienten? Jusletter

  77. Nijenhuis ER (2001) Somatoform dissociation: major symptoms of dissociative disorders. J Trauma Dissociation 1(4):7–32

    Article  Google Scholar 

  78. Nimnuan C, Hotopf M, Wessely S (2000) Medically unexplained symptoms: how often and why are they missed? QJM 93(1):21–28

    Article  CAS  PubMed  Google Scholar 

  79. Nimnuan C, Hotopf M, Wessely S (2001a) Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 51(1):361–367

    Article  CAS  PubMed  Google Scholar 

  80. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M (2001b) How many functional somatic syndromes? J Psychosom Res 51(4):549–557

    Article  CAS  PubMed  Google Scholar 

  81. Organization WH (1950) The preamble of the constitution of the World Health Organization

  82. Percy A, McAlister S, Higgins K, McCrystal P, Thornton M (2005) Response consistency in young adolescents’ drug use self‐reports: a recanting rate analysis. Addiction 100(2):189–196

    Article  PubMed  Google Scholar 

  83. Prause J, Dooley D, Ham-Rowbottom KA, Emptage N (2007) Alcohol drinking onset: a reliability study. J Child Adolesc Subst Abuse 16(4):79–90

    Article  Google Scholar 

  84. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 264(19):2511–2518

    Article  CAS  PubMed  Google Scholar 

  85. Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ (2003) Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol 30(6):1318–1325

    PubMed  Google Scholar 

  86. Roth B (1976) Narcolepsy and hypersomnia: review and classification of 642 personally observed cases. Schweiz Arch Neurol Neurochir Psychiatr 119(1):31–41

    CAS  PubMed  Google Scholar 

  87. Sachs J, Habermeyer E (2012) Qualifizierung und Qualitätskontrolle in der forensischen Psychiatrie. Forens Psychiatr Psychol Kriminol 1–8

  88. Sanderson K, Andrews G (2002) Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatr Serv 53(1):80–86

    Article  PubMed  Google Scholar 

  89. Schandelmaier S, Fischer K, Mager R, Hoffmann-Richter U, Leibold A, Bachmann MS, Kedzia S, Jeger J, Marelli R, Kunz R (2013) Evaluation of work capacity in Switzerland: a survey among psychiatrists about practice and problems. Swiss Med Wkly 143

  90. Schellart AJ, Mulders H, Steenbeek R, Anema JR, Kroneman H, Besseling J (2011) Inter-doctor variations in the assessment of functional incapacities by insurance physicians. BMC Public Health 11(1):864

    Article  PubMed Central  PubMed  Google Scholar 

  91. Schmidt LM, Hesse M, Lykke J (2011) The impact of substance use disorders on the course of schizophrenia—a 15-year follow-up study: Dual diagnosis over 15 years. Schizophr Res 130(1):228–233

    Article  PubMed  Google Scholar 

  92. Selzer JA, Lieberman JA (1993) Schizophrenia and substance abuse. Psychiatr Clin North Am 16(2):401–412

  93. Shillington AM, Clapp JD, Reed MB, Woodruff SI (2010) Adolescent alcohol use self-report stability: a decade of panel study data. J Child Adolesc Subst Abus 20(1):63–81

    Article  Google Scholar 

  94. Shillington AM, Woodruff SI, Clapp JD, Reed MB, Lemus H (2012) Self-reported age of onset and telescoping for cigarettes, alcohol, and marijuana: across eight years of the national longitudinal survey of youth. J Child Adolesc Subst Abus 21(4):333–348

    Article  Google Scholar 

  95. Sicras-Mainar A, Rejas J, Navarro R, Blanca M, Morcillo Á, Larios R, Velasco S, Villaroya C (2009) Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Res Ther 11(2):R54

    Article  PubMed Central  PubMed  Google Scholar 

  96. Smith GR, Monson RA, Ray DC (1986) Patients with multiple unexplained symptoms: their characteristics, functional health, and health care utilization. Arch Intern Med 146(1):69–72

    Article  PubMed  Google Scholar 

  97. Smith JP, Book SW (2010) Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment. Addict Behav 35(1):42–45

    Article  PubMed Central  PubMed  Google Scholar 

  98. Spearing NM, Connelly LB, Gargett S, Sterling M (2012) Does injury compensation lead to worse health after whiplash? A systematic review. Pain 153(6):1274–1282

    Article  PubMed  Google Scholar 

  99. Sterner Y, Gerdle B (2004) Acute and chronic whiplash disorders-a review. J Rehabil Med 36(5):193–210

    Article  PubMed  Google Scholar 

  100. Stöhr S, Bollag Y, Auerbach H, Eichler K, Imhof D, Fabbro T, Gyr N, Stöhr S (2011) Quality assessment of a randomly selected sample of Swiss medical expertises. Swiss Med Wkly 141:w13173

    PubMed  Google Scholar 

  101. Sullivan P, Smith W, Buchwald D (2002) Latent class analysis of symptoms associated with chronic fatigue syndrome and fibromyalgia. Psychol Med 32(5):881–888

    Article  CAS  PubMed  Google Scholar 

  102. Swendsen JD, Merikangas KR (2000) The comorbidity of depression and substance use disorders. Clin Psychol Rev 20(2):173–189

    Article  CAS  PubMed  Google Scholar 

  103. Tages-Anzeiger (2014) Auch Arztzeugnisse sind nicht mehr verbindlich. http://www.tagesanzeiger.ch/schweiz/standard/Auch-Arztzeugnisse-sind-nicht-mehr-verbindlich/story/14939157

  104. Tanaka M, Watanabe Y (2010) A new hypothesis of chronic fatigue syndrome: co-conditioning theory. Med Hypotheses 75(2):244–249

    Article  PubMed  Google Scholar 

  105. Thomas Gächter DT (2011) Schmerzrechtsprechung am Wendepunkt? Jusletter

  106. Tore Gran J (2003) The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17(4):547–561

    Article  Google Scholar 

  107. Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ (2010) Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord 24(4):412–426

    Article  PubMed Central  PubMed  Google Scholar 

  108. Van Der Werff E, Verboom C, Penninx B, Nolen W, Ormel J (2010) Explaining heterogeneity in disability associated with current major depressive disorder: effects of illness characteristics and comorbid mental disorders. J Affect Disord 127(1):203–210

    Article  CAS  PubMed  Google Scholar 

  109. Verboom C, Sentse M, Sijtsema J, Nolen W, Ormel J, Penninx B (2011) Explaining heterogeneity in disability with major depressive disorder: effects of personal and environmental characteristics. J Affect Disord 132(1):71–81

    Article  CAS  PubMed  Google Scholar 

  110. Weltwoche (2012) Karriere einer erfundenen Krankheit. In: Weltwoche. http://www.weltwoche.ch/ausgaben/2012–38/karriere-einer-erfundenen-krankheit-die-weltwoche-ausgabe-382012.html

  111. Wessely S (1990) Old wine in new bottles: neurasthenia and ‚ME‘. Psychol Med 20(01):35–53

    Article  CAS  PubMed  Google Scholar 

  112. Wessely S, Nimnuan C, Sharpe M (1999) Functional somatic syndromes: one or many? Lancet 354(9182):936–939

    Article  CAS  PubMed  Google Scholar 

  113. Whitehead WE, Palsson O, Jones KR (2002) Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 122(4):1140–1156

    Article  PubMed  Google Scholar 

  114. Winckler P, Foerster K (1996) Zum Problem der „zumutbaren Willensanspannung“in der sozialmedizinischen Begutachtung. Med Sach 92(4):120–124

    Google Scholar 

  115. Wittchen H-U, Carter R, Pfister H, Montgomery S, Kessler R (2000) Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol 15(6):319–328

    Article  CAS  PubMed  Google Scholar 

  116. Wolfe F (2009) Fibromyalgia wars. J Rheumatol 36(4):671–678

    Article  PubMed  Google Scholar 

  117. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33(2):160–172

    Article  CAS  PubMed  Google Scholar 

  118. Wolitzky-Taylor K, Bobova L, Zinbarg RE, Mineka S, Craske MG (2012) Longitudinal investigation of the impact of anxiety and mood disorders in adolescence on subsequent substance use disorder onset and vice versa. Addict Behav 37(8):982–985

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gutachtenstelle für Zivil- und Öffentlichrechtliche Fragestellungen, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Psychiatrische Universitätsklinik Zürich, 8021, Zürich, Schweiz

    Carlos Canela, Roman Schleifer, Erich Seifritz & Michael Liebrenz

  2. MEDAS Zentralschweiz, Hirschengraben 33, 6003, Luzern, Schweiz

    Jörg Jeger

  3. Zentrum für Begutachtung, Rehaklinik Bellikon, 5454, Bellikon, Schweiz

    Gerhard Ebner

  4. Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Drive, 10032, New York, NY, USA

    Michael Liebrenz

Authors
  1. Carlos Canela
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roman Schleifer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jörg Jeger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gerhard Ebner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erich Seifritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael Liebrenz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlos Canela.

Ethics declarations

Interessenkonflikt

C. Canela, R. Schleifer, J. Jeger, G. Ebner E. Seifritz, M. Liebrenz geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Canela, C., Schleifer, R., Jeger, J. et al. Die invalidenversicherungsrechtliche Begutachtung in der Schweiz vor dem Hintergrund der letzten Gesetzesrevision und neueren Rechtsprechung. Forens Psychiatr Psychol Kriminol 9, 106–116 (2015). https://doi.org/10.1007/s11757-014-0302-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11757-014-0302-3

Schlüsselwörter

Keywords

Search

Navigation